The Pharma Perspective

How Sustainable Is Your Medicine? Spain Now Prices It In | Nerea Blanque Catalina | EP 10

Green HTA, Spain's world-first sustainability-linked drug pricing, and why the US freeloads too: on this episode of The Pharma Perspective, pricing and market access expe

Will AI Replace Medical Writers? | Virginia Chachati | EP 9

Medical writing rates, AI-proof writing tests, and the telltale signs of AI-generated content: on this episode of The Pharma Perspective, pharmacist turned medical writer

Most Favored Nation Pricing, Tariffs & the Rise of China | Neil Grubert | EP 8

Most Favored Nation (MFN) drug pricing, pharma tariffs, and China overtaking the US in new drug launches: on this episode of The Pharma Perspective, market access and pol

Pharma's Worst Job Market in 30 Years: Top Recruiter Reveals What to Do Now | Grant Coren | EP 7

In this episode of The Pharma Perspective podcast, Grant Coren, life science recruiter with over 30 years of experience and founder of his own executive search practice,

Rethinking Medications: From Academic Detailing to Broken Drug Regulation | Jerry Avorn | EP 6

In this episode of The Pharma Perspective podcast, Jerry Avorn, Professor of Medicine at Harvard Medical School and author of "Rethinking Medications," discusses the stat

Measuring What Patients Actually Care About | Katja Rüdell | EP 5

In this episode of The Pharma Perspective podcast, Katja Rüdell, one of the world's leading clinical outcome assessment and patient-reported outcomes experts, discusses t

What Does the ABPI Actually Do? | Jack Neill-Hall | EP 4

In this episode of The Pharma Perspective podcast, Jack Neill-Hall from the Association of the British Pharmaceutical Industry (ABPI) discusses the UK pharmaceutical pric

Is Raising the NICE Threshold Bad for NHS Patients? | Karl Claxton | EP 3

In this episode of "The Pharma Perspective", I speak with Karl Claxton, Professor of Economics at the University of York and founding NICE Appraisal Committee member, abo

Starting a Pharma Consultancy in a Pandemic: The PharmacoEvidence Story | Barinder Singh | EP 2

Join me in my discussion with Barinder Singh, Founder of PharmacoEvidence, who quit his stable HEOR job in 2020—amid a pandemic and with a baby on the way—to start his ow

How to Build a Meaningful Pharma Career – Leadership Lessons from a GM | Peter Wickersham | EP 1

Join me in my discussion with Peter Wickersham, Pharma Vice President & General Manager with 25+ years of experience, as we explore leadership, career growth, and navigat